ClinicalTrials.gg
RecruitingNCT03755401RCT of TFPPUpdated Nov 12, 2026

Post-Traumatic Stress Disorder Focused Psychodynamic Psychotherapy

An interventional study of TFPP and TAU in PTSD, sponsored by Montefiore Medical Center. Recruiting at 1 site in United States. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by Montefiore Medical Center · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Nov 2018; still recruiting 8 years later.
Updated Nov 12, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
75
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 1,664 studies in Stress Disorders, Post-Traumatic with a site in United States — 340 open to participants now, 403 under way, 18 of them phase 3. Stress Disorders, Post-Traumatic · United States.

Planned enrollment
678th of 1,491
75 · median 65
Started
2018
with 59 others
No phase
1,012 of 1,664
234 open now
Primary completion
2027-12
later than 248 of 402 live
Registered
882nd of 1,664
by date

Among the 1,664 studies in Stress Disorders, Post-Traumatic with a site in United States, this one is the 678th largest by planned enrollment of the 1,491 interventional ones that give a count, is one of 60 that started in 2018, is one of 1,012 with no phase, reaches primary completion later than 248 of the 402 other live ones, and was the 882nd registered.

Stress Disorders, Post-Traumatic

2,689 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 605 are open to participants now.

Browse Stress Disorders, Post-Traumatic studies →

Open to participants now

340 of the 1,664 studies in Stress Disorders, Post-Traumatic with a site in United States are open now. Recruiting first, the newest first:

335 more — sign in →

All 340 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 416 Stress Disorders, Post-Traumatic studies recruiting now, 188 (45%) set no upper age limit and 202 (49%) stop at 75 or younger; 62 take children under 18; 88 take healthy volunteers.

This study: 18 Years to 70 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,664 studies in Stress Disorders, Post-Traumatic with a site in United States, or all of them as a file.
02

Study summary

This is a randomized controlled trial of Trauma-Focused Psychodynamic Psychotherapy (TFPP) in comparison with TAU (at the VA) in a 2:1 ratio in 75 Veterans with PTSD who have not responded to standard treatment at the VA.

Read the detailed description

Veterans with PTSD are a highly vulnerable population with tremendous disability and unmet needs. Few VA patients with PTSD now actually receive evidence-based psychotherapy because current exposure-based treatments have low uptake. The project goal is to expand the range of PTSD psychotherapy treatments available at Veterans Administration Medical Centers. This pilot trauma recovery proposal takes the next step in translating a brief efficacious psychotherapy developed and tested for panic disorder, Panic Focused Psychodynamic Psychotherapy (PFPP) for Veterans with PTSD at the VA New York Harbor Healthcare System (VA NYHHCS). PFPP was developed, manualized, and studied in RCTs over the past two decades. We hope that Trauma-Focused Psychodynamic Psychotherapy (TFPP), an adaptation of PFPP, with its high response rates in panic disorder with/without agoraphobia, and non-exposure protocol, will fill crucial gaps in Veteran care. A major challenge facing psychotherapy research is translating and implementing efficacious therapies to the community. No psychodynamic psychotherapy for anxiety or PTSD has achieved this in the US. This pilot RCT represents a paradigm shift in its approach to trauma. TFPP will be the only PTSD treatment for Veterans to incorporate Veterans' input into refinement of the treatment as this project progresses. TFPP targets aspects of traumatic experience and approaches Veterans' lives more broadly than the symptom-focused treatments the VA currently offers our traumatized Veterans.

03

Conditions studied

  • PTSD

Keywords

  • psychotherapy
  • psychodynamic psychotherapy
04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Reporting moderate PTSD, as defined by a CAPS score of >40
  • Have at least one of the following history with CPT and/or PE:

    • offered and declined
    • dropped out of treatment
    • been determined unsuitable by their treatment team
    • received treatment but continue to experience symptoms meeting entrance criteria.
  • Require stabilization on psychiatric medication for 2 month period prior to entry into study to avoid confounding treatments

Exclusion criteria

Exclusion Criteria:

  • Presence of SCID-5 assessed psychotic disorder, bipolar disorder, or substance use that would interfere with trial demands
  • Severe suicidality that would require immediate crisis management
  • Organic mental syndromes, delirium, or unstable medical conditions that would interfere with trial demands
  • Inability to meet trial demands.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
75 participants (estimated)

Study arms

  • Experimental
    TFPP

    TFPP is a manualized 16-24 session psychodynamic psychotherapy targeted on trauma symptoms of PTSD

    Other: TFPP

  • Active comparator
    TAU

    TAU in this study is treatment for PTSD as currently delivered at the VA

    Other: TAU

Interventions

  • OtherTFPP

    Trauma-Focused Psychodynamic Psychotherapy

    Also known as: psychodynamic psychotherapy

  • OtherTAU

    treatment as usual at the VA for PTSD

06

What researchers measure

Primary outcomes

  1. Change in PTSD symptoms as per DSM-5 as measured by CAPS-5

    Clinician-Administered PTSD Scale for DSM-5 (CAPS-5). Low score indicates fewer PTSD symptoms, high score indicates more PTSD symptoms.

    Time frame: baseline, 16 weeks (termination), 3 month follow-up

Secondary outcomes

  1. Change in anxiety symptoms as measured by HARS.

    Hamilton Anxiety Rating Scale (HARS). Low score indicates fewer state anxiety symptoms, high score indicates greater state anxiety symptoms

    Time frame: baseline, 16 weeks (termination), 3 month follow-up

  2. Change in reflective capacity as measured by RF score.

    Reflective Function Scale (RF). Low score indicates poor ability to reflect on relationships and self, high score, indicates better capacity to reflect on others and self.

    Time frame: baseline, 16 weeks (termination), 3 month follow-up

  3. Change in depression symptoms as measured by HDRS.

    Hamilton Depression Rating Scale (HDRS). Low score indicates few depressive symptoms, high score indicates high level of depressive burden (depression)

    Time frame: baseline, 16 weeks (termination), 3 month follow-up

  4. Change in mental and physical symptoms as measured by VR-12.

    Veterans RAND 12-Item Health Survey (VR-12). The results of the VR-12 are summarized as two scores - a Mental Component Score (MCS) and a Physical Component Score (PCS). The scores may be reported as Z-scores (difference compared to the population average, measured in standard deviations). The United States population average PCS and MCS are both 50 points. The United States population standard deviation is 10 points. Therefore, each increment of 10 points above or below 50 corresponds to one standard deviation away from the population average.

    Time frame: baseline, 16 weeks (termination), 3 month follow-up

  5. Change in work and social adjustment as measured by WSAS.

    Work and Social Adjustment Scale (WSAS). Low score indicates good social and work adjustment, high score indicates impairment socially and at work.

    Time frame: baseline, 16 weeks (termination), 3 month follow-up

  6. Change in degree of limitation in ability to work as measured by WLQ

    Work Limitations Questionnaire (WLQ). Low score indicates few limitations at work, high score indicates many limitations at work

    Time frame: baseline, 16 weeks (termination), 3 month follow-up

  7. Childhood abuse history and trauma with CTQ

    Childhood Trauma Questionnaire (CTQ). Several different domains: Emotional Abuse: None=5-8; Low=9-12; Moderate=13-15; Severe=16+ Physical Abuse: None=5-7; Low=8-9; Moderate=10-12; Severe=13+ Sexual Abuse: None=5; Low=6-7; Moderate=8-12; Severe=13+ Emotional Neglect: None=5-9; Low=10-14; Moderate=15-17; Severe=18+ Physical Neglect: None=5-7; Low=8-9; Moderate=10-12; Severe=13+

    Time frame: baseline

  8. Change in adult separation anxiety symptoms as measured by the SCI-SAS

    Separation anxiety-child and adult measure rating scale (SCI-SAS). Separate scores generated for childhood separation anxiety and adult separation anxiety. Low scores indicate few separation anxiety symptoms, high scores indicate large separation anxiety burden.

    Time frame: baseline, 16 weeks (termination), 3 month follow-up

  9. Assessment of life events on LEC.

    Life Events Checklist (LEC). No composite score-tracks traumatic life events

    Time frame: baseline

07

Study locations

1 of 1 sites recruiting
  • VA New York Harbor Healthcare System - Manhattan Campus
    New York, New York 10010, United States
    Recruiting
08

References and documents

Publications

  • Busch FN, Milrod BL. Trauma-Focused Psychodynamic Psychotherapy. Psychiatr Clin North Am. 2018 Jun;41(2):277-287. doi: 10.1016/j.psc.2018.01.005. PubMed 29739526 ↗
  • Kehn M, Milrod B, Chen CK. Clinical Case of Trauma-Focused Psychodynamic Psychotherapy for a Veteran With PTSD and Race-Based Trauma. Am J Psychother. 2024 Sep 1;77(3):146-150. doi: 10.1176/appi.psychotherapy.20230040. No abstract available. PubMed 39277802 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2018 (actual). Primary completion is estimated for Dec 2027, 109 months after the start.

Of 1,066 non-industry interventional studies with no phase under Stress Disorders, Post-Traumatic, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's planned 109 months is above that.

Counting every sponsor, half of 1,094 studies reached it within 35 months; a quarter within 17 and three quarters within 53.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 12, 2026: primary completion May 2027 → Dec 2027 and completion May 2027 → Dec 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Nov 13, 2018
First posted
Nov 28, 2018
StartActual
Nov 2, 2018
Primary completionEst.
Dec 2027was May 2027
CompletionEst.
Dec 2027was May 2027
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
May 2027→Dec 2027
Nov 12, 2026
Study completion
May 2027→Dec 2027
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    Primary completion May 2027→Dec 2027
    Study completion May 2027→Dec 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT03755401
Collaborators
VA New York Harbor Healthcare System, Weill Medical College Clinical Science Translation Center, American Psychoanalytic Association (APsA), International Psychoanalytic Association (IPA), National Center for Advancing Translational Sciences (NCATS)
Responsible party
Sponsor
First posted
Nov 28, 2018
Start date
Nov 2, 2018
Primary completion
Dec 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Nov 12, 2026

Study contacts

Emily Villeveuve
Contact
Emily.Villeneuve@va.gov
(212) 686-7500 ext. 3003
Cory K Chen, Ph.D.
Contact
Cory.Chen@va.gov
(212) 686-7500 ext. 4002
Barbara Milrod, MD
principal investigator · Weill Medical College of Cornell University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion